Home › Asset managers › Compare 2024-2025 › John Hancock vs Invesco
John Hancock 2024-2025 · Invesco 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 11,767 | 10,089 | 735 | 943 | 93.2% | 90.8% |
| Board proposals | 9,482 | 8,187 | 677 | 618 | 92.4% | 90.4% |
| E&S shareholder proposals | 236 | 114 | 13 | 109 | 89.8% | 81.6% |
| Other items | 2,049 | 1,788 | 45 | 216 | 97.5% | 93.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
735 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | John Hancock | Invesco |
|---|---|---|---|---|---|---|
| AMERICAN HEALTHCARE REIT INC. | November 7, 2024 | To approve, on an advisory (non-binding) basis, the compensation paid to our named executive officers for the year ended December 31, 2023. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| AMERICAN SOFTWARE INC. | August 20, 2024 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| ANI PHARMACEUTICALS INC. | May 22, 2025 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| ANNEXON INC. | June 5, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| ANYWHERE REAL ESTATE INC. | May 7, 2025 | Approval of the Third Amended and Restated 2018 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| APOGEE ENTERPRISES INC. | June 25, 2025 | Advisory vote to approve Apogee's executive compensation; Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 9 funds |
| APPLIED THERAPEUTICS INC. | June 9, 2025 | To approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ARAMARK | January 24, 2025 | To approve, in a non-binding advisory vote, the compensation paid to the named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 11 funds |
| ARBUTUS BIOPHARMA CORP. | May 21, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| ARCELLX INC. | May 28, 2025 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 5 funds |
| ARCELORMITTAL SA | May 6, 2025 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ARCHER AVIATION INC. | June 27, 2025 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | June 6, 2025 | Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| ARDELYX INC. | June 18, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| ARES COMMERCIAL REAL ESTATE CORP | May 27, 2025 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2024, as described in the 2025 Proxy Statement. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| ARTEMIS GOLD INC | August 1, 2024 | ELECTION OF DIRECTOR: DAVID BLACK Director Elections |
Board | For | ABSTAIN 1 fund |
FOR 1 fund |
| ARTISAN PARTNERS ASSET MANAGEMENT INC | June 4, 2025 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 7 funds |
| ARVINAS INC. | June 25, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| ASPEN AEROGELS INC. | April 30, 2025 | Approval of the Aspen Aerogels Amended and Restated 2023 Equity Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| ATLAS COPCO A | April 29, 2025 | REELECT PETER WALLENBERG JR AS DIRECTOR Director Elections |
Board | Not determined | AGAINST 4 funds |
FOR 10 funds |
| ATLAS LITHIUM CORP. | May 28, 2025 | The approval of an amendment to the Company's 2023 Stock Incentive Plan to increase the shares of common stock reserved for issuance under the Plan from two million (2,000,000) shares to three million (3,000,000) shares. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ATOMERA INC. | May 15, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ATOSS SOFTWARE SE | April 30, 2025 | Elect Klaus Bauer to the Supervisory Board Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ATOSS SOFTWARE SE | April 30, 2025 | Elect Moritz Zimmermann to the Supervisory Board Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ATOSS SOFTWARE SE | April 30, 2025 | Elect Rolf Vielhauer von Hohenhau to the Supervisory Board Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ATOSSA THERAPEUTICS INC. | May 8, 2025 | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| AURA MINERALS INC | June 16, 2025 | ELECTION OF DIRECTOR: PAULO DE BRITO FILHO Director Elections |
Board | Not determined | ABSTAIN 2 funds |
WITHHOLD 1 fund |
| AURINIA PHARMACEUTICALS INC. | May 15, 2025 | Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| AUTOLIV INC. | May 8, 2025 | Election of Directors: Leif Johansson Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 3 funds |
| AVANOS MEDICAL INC. | April 24, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 7 funds |
| AVEPOINT INC. | May 6, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 7 funds |
| AVIAT NETWORKS INC. | November 6, 2024 | Advisory, non-binding vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| AVIAT NETWORKS INC. | November 6, 2024 | Approval of the Second Amended and Restated 2018 Incentive Plan of the Company. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| AVITA MEDICAL INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers; and Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| AXOGEN INC. | June 18, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 5 funds |
| BANK7 CORP. | May 15, 2025 | Advisory vote on named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| BANQUE CANTONALE VAUDOISE | May 8, 2025 | REELECT PIERRE-ALAIN URECH AS DIRECTOR Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| BARK INC. | September 12, 2024 | Approve, on an advisory basis, the compensation of the company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| BARRETT BUSINESS SERVICES INC. | June 2, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| BAYCOM CORP | June 17, 2025 | An advisory (non-binding) vote on executive compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| BEAUTY HEALTH CO. | June 12, 2025 | Approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| BEAZER HOMES USA INC. | February 6, 2025 | An advisory vote regarding the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 5 funds |
| BEL FUSE INC. | May 27, 2025 | With respect to the approval, on an advisory basis, of the executive compensation of Bel's named executive officers as described in the Proxy Statement Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| BELIMO HOLDING AG | March 24, 2025 | REAPPOINT SANDRA EMME AS MEMBER OF THE NOMINATION AND COMPENSATION COMMITTEE Compensation |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BELIMO HOLDING AG | March 24, 2025 | REELECT MARTIN ZWYSSIG AS DEPUTY CHAIR Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BELIMO HOLDING AG | March 24, 2025 | REELECT MARTIN ZWYSSIG AS DIRECTOR Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BENTLEY SYSTEMS INC. | May 22, 2025 | To approve, on an advisory (non-binding) basis, the compensation paid to the Company's named executive officers Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 8 funds |
| BERRY GLOB | February 25, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement, which proposal is referred to as the "Berry Advisory Compensation Proposal." Say-on-Pay |
Board | Not determined | AGAINST 7 funds |
FOR 9 funds |
| BEYOND INC. | May 15, 2025 | The approval of an amendment and restatement of the Company's Amended and Restated 2005 Equity Incentive Plan (the "2005 Plan"). Compensation |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| BGC GROUP INC. | September 16, 2024 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 11 funds |
| BIO-TECHNE CORP | October 24, 2024 | Approve, on an advisory basis, the compensation of our executive officers. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 21 funds |
| BIOCRYST PHARMACEUTICALS INC. | June 12, 2025 | To hold a non-binding, advisory vote regarding executive compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 5 funds |
| BIOLIFE SOLUTIONS INC. | August 1, 2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 8 funds |
| BLACKLINE INC. | May 8, 2025 | Approval, on a non-binding, advisory basis, of the 2024 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| BLINK CHARGING CO. | June 26, 2025 | Approve, on a non-binding advisory basis, the compensation paid to our executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| BLUEBIRD BIO INC. | December 4, 2024 | The approval, on a non-binding, advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| BLUEPRINT MEDICINES CORP. | June 18, 2025 | Approval of a non-binding advisory vote on the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 9 funds |
| BOUVET ASA | May 7, 2025 | Reelect Sverre Finn Hurum as Director Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| BOX INC. | June 27, 2025 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 5,000,000 shares. Compensation |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| BOYD GAMIN | May 8, 2025 | Advisory vote on executive compensation. Say-on-Pay |
Board | Not determined | FOR 6 funds |
AGAINST 8 funds |
| BRANDYWINE REALTY TRUST | May 21, 2025 | Adoption of an amendment to the 2023 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 4 funds |
| BRAZE INC. | June 26, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 7 funds |
| BRIDGEBIO PHARMA INC. | June 20, 2025 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares. Compensation |
Board | For | AGAINST 5 funds |
FOR 7 funds |
| BRIDGEWATER BANCSHARES INC. | April 22, 2025 | Approve, on a non-binding advisory basis, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| BRIGHTVIEW HOLDINGS INC. | March 4, 2025 | To approve a non-binding advisory resolution approving the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 5 funds |
| BROADRIDGE FINANCIAL SOLUTIONS INC. | November 14, 2024 | Advisory vote to approve the compensation of the Company's Named Executive Officers (the Say on Pay Vote). Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 24 funds |
| BROADSTONE NET LEASE INC | May 1, 2025 | To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers as described in the Company's 2025 proxy statement. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 6 funds |
| BROOKFIELD INFRASTRUCTURE CORP. | June 24, 2025 | Elect Director Jeffrey Blidner Director Elections |
Board | For | ABSTAIN 2 funds |
FOR 1 fund |
| BRUKER CORP. | May 29, 2025 | Approval of the adoption of the Bruker Corporation 2026 Incentive Compensation Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect Christopher Halmy as director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect Robert Gillespie as director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BYRNA TECHNOLOGIES INC. | November 20, 2024 | Approval, by non-binding vote, the Company's executive compensation. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| C.H. ROBINSON WORLDWIDE INC. | May 8, 2025 | To approve the Amended and Restated 2022 Equity Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 14 funds |
| CALIX INC. | May 8, 2025 | To approve, on a non-binding, advisory basis, Calix's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| CAPRICOR THERAPEUTICS INC. | May 22, 2025 | APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| CAREDX INC. | June 12, 2025 | Approval of an amendment to 2024 Equity Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 7 funds |
| CAREDX INC. | June 12, 2025 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 12 funds |
| CARL ZEISS MEDITEC AG | March 26, 2025 | Approve Remuneration Report Compensation |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CARL ZEISS MEDITEC AG | March 26, 2025 | Elect Andreas Pecher to the Supervisory Board Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CARL ZEISS MEDITEC AG | March 26, 2025 | Elect Angelika Bullinger-Hoffmann to the Supervisory Board Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CARRIAGE SERVICES INC. | May 13, 2025 | To approve on an advisory basis our 2024 Named Executive Officers' compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| CARTESIAN THERAPEUTICS INC. | June 13, 2025 | To approve, on a non-binding and advisory basis, a resolution approving the compensation of Cartesian Therapeutics, Inc.'s named executive officers, as described in the accompanying proxy statement under "Executive and Director Compensation." Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CARVANA CO. | May 5, 2025 | To consider the approval, by an advisory vote, of the compensation of our named executive officers as disclosed in the Proxy Statement ("say-on-pay"). Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 11 funds |
| CASSAVA SCIENCES INC. | May 23, 2025 | To approve, by a non-binding advisory vote, 2024 executive compensation for the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CATALYST PHARMACEUTICALS INC. | May 20, 2025 | To approve, on an advisory basis, the 2024 compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 11 funds |
| CATHAY GENERAL BANCORP | May 12, 2025 | Approval, on a non-binding advisory basis, of the compensation paid to Cathay General Bancorp's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 9 funds |
| CELCUITY INC. | May 13, 2025 | To approve, by a non-binding and advisory vote, compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CENTURI HOLDINGS INC. | April 16, 2025 | Approval, on a non-binding, advisory basis, of executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| CENTURY ALUMINUM CO. | June 16, 2025 | Proposal to approve, on an advisory basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| CERUS CORP. | June 3, 2025 | The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| CEVA INC. | May 5, 2025 | To approve an amendment and restatement of the Company's 2011 Equity Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CHARGEPOINT HOLDINGS INC. | July 9, 2024 | The advisory approval of the compensation of our named executive officers ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 7 funds |
| CHEGG INC. | June 4, 2025 | To approve the Chegg, Inc. Amendment to the 2023 Equity Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| CHEMED CORP. | May 19, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 10 funds |
| CHEMUNG FINANCIAL CORP. | June 3, 2025 | To approve the Chemung Financial Corporation 2025 Equity Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CHEMUNG FINANCIAL CORP. | June 3, 2025 | To approve, on a non-binding advisory basis, the compensation of the Named Executive Officers of the Corporation ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| CHEWY | July 11, 2024 | To approve the Chewy, Inc. 2024 Omnibus Incentive Plan, including an increase in the number of shares reserved for issuance by 80,000,000 shares. Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CHILDREN'S PLACE INC. | May 7, 2025 | To approve, by non-binding vote, executive compensation as described in the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| CHURCHILL DOWNS INC. | April 22, 2025 | To approve, on a non-binding advisory basis, the Company's executive compensation as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| CIBUS INC. | May 22, 2025 | To approve, on an advisory basis, the compensation of the company's Named Executive Officers Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 2 funds |
← Previous Page 2 of 8 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.